IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and provided 2025 corporate guidance and program updates. Presentation by Yujiro S. Hata , Chief Executive Officer, IDEAYA Biosciences, followed by analyst-hosted Q&A with Anupam Rama , Managing Director, US SMID Biotechnology Equity Research, J.P. Morgan
Monday, January 13, 2025
SOUTH SAN FRANCISCO
IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and provided 2025 corporate guidance and program updates. Presentation by Yujiro S. Hata , Chief Executive Officer, IDEAYA Biosciences, followed by analyst-hosted Q&A with Anupam Rama , Managing Director, US SMID Biotechnology Equity Research, J.P. Morgan
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox